DNLI
Denali Therapeutics Inc
20.40$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | -2.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | |
| 0.65 | 0.02 | 0.01 | 0.01 | – | – | – | 0.02 | 0.59 | 0.02 | 0.02 | 0.00 | 0.58 | |
| 0.01 | -2.22 | -0.01 | -0.01 | – | – | – | -0.02 | -0.59 | -0.02 | -0.02 | 0.02 | -0.56 | |
| 0.65 | 0.78 | 0.72 | 0.54 | 0.58 | 0.59 | 0.68 | 0.60 | 0.59 | 0.56 | 0.56 | 0.52 | 2.14 | |
| 0.18 | 0.18 | 0.17 | 0.15 | 0.15 | 0.18 | 0.17 | 0.19 | 0.21 | 0.22 | 0.18 | 0.19 | 0.77 | |
| 0.84 | 0.96 | 0.79 | 0.69 | 0.73 | 0.76 | 0.85 | 0.79 | 0.80 | 0.77 | 0.72 | 0.72 | 2.89 | |
| -0.83 | -0.96 | -0.79 | -0.69 | -0.73 | -0.76 | -0.85 | -0.79 | -0.80 | -0.78 | -0.74 | -0.70 | -2.90 | |
| – | 0.15 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.72 | -0.86 | -0.68 | -0.59 | -0.63 | -0.67 | -0.78 | -0.72 | -0.74 | -0.73 | -0.69 | -0.68 | -2.73 | |
| 0.02 | 0.00 | 0.01 | – | – | 0.00 | – | – | – | 0.00 | – | – | – | |
| -0.72 | -0.86 | -0.68 | -0.59 | -0.63 | -0.67 | -0.78 | -0.72 | -0.74 | -0.73 | -0.69 | -0.68 | -2.73 | |
| -0.71 | -0.85 | -0.87 | -0.58 | -0.62 | -0.66 | -0.76 | -0.70 | -0.71 | -0.71 | -0.67 | -0.66 | -2.65 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.